AlphaMark Advisors’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-260
| Closed | – | – | 580 |
|
|
2020
Q4 | $0 | Hold |
260
| – | – | ﹤0.01% | 580 |
|
|
2020
Q3 | $1K | Sell |
260
-241,647
| -100% | -$929K | ﹤0.01% | 527 |
|
|
2020
Q2 | $866K | Buy |
241,907
+2,289
| +1% | +$8.19K | 0.37% | 51 |
|
|
2020
Q1 | $911K | Buy |
239,618
+415
| +0.2% | +$1.58K | 0.5% | 42 |
|
|
2019
Q4 | $720K | Buy |
+239,203
| New | +$720K | 0.3% | 59 |
|